ProxAI leverages GenAI to design peptides that target disease-triggering genes previously considered "undruggable." Unlike traditional small molecule drugs that target only 20% of the human genome, we access the untapped 80%, as well as the 20%. Combined with our technology, this results in a success rate of up to 90% in drug development.
Company Details
- Employees
- 4
- Founded
- -
- Address
- Montreal, Quebec, Ca
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://prox-ai.com
- HQ
- Montreal, Quebec
Proxai Questions
Proxai's website is http://prox-ai.com
Proxai's LinkedIn profile is https://ca.linkedin.com/company/proxai
Proxai has
4 employees.
View email and phone details for 4
employees at Proxai.
Proxai's industry is
Biotechnology Research
Proxai's top competitors are
Simmunome Inc.,
9bio Therapeutics,
Seragene Therapeutics,
Kapoose Creek Bio,
Neiges Biotechnologies,
Htuo Biosciences,
Phinc. Modeling,
Cerecura Nanotherapeutics,
Neuropeutics Inc,
Ability Biotherapeutics.
Proxai's categories are Biotechnology Research
Proxai's founding year is 2024
